BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8672852)

  • 1. Imaging and biodistribution of 125I tyramine oligonucleotide in nude mice bearing human breast tumor. Preliminary report.
    Cammilleri S; Perdereau B; Brixy F; Pierga JY; Benyahia B; Chypre C; Magdelenat H
    Bull Cancer; 1996 Jan; 83(1):23-26. PubMed ID: 8672852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of iodine-125 tyramine transforming growth factor alpha antisense oligonucleotide in athymic mice with a human mammary tumour xenograft following intratumoral injection.
    Cammilleri S; Sangrajrang S; Perdereau B; Brixy F; Calvo F; Bazin H; Magdelenat H
    Eur J Nucl Med; 1996 Apr; 23(4):448-52. PubMed ID: 8612667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on biodistribution and imaging of radioiodinated antisense oligonucleotides in nude mice bearing human lymphoma].
    Shen J; Wang RF; Zhang CL; Liu M; Guo FQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):655-9. PubMed ID: 15605104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and biodistribution of VIP-125I-ASON].
    Ou XH; Tan TZ; Li YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):713-6. PubMed ID: 16235546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model.
    Dewanjee MK; Ghafouripour AK; Kapadvanjwala M; Dewanjee S; Serafini AN; Lopez DM; Sfakianakis GN
    J Nucl Med; 1994 Jun; 35(6):1054-63. PubMed ID: 8195870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological disposition and imaging of a radioiodinated alkylphosphocholine in two rodent models of breast cancer.
    Rampy MA; Brown RS; Pinchuk AN; Weichert JP; Skinner RW; Fisher SJ; Wahl RL; Gross MD; Ethier SP; Counsell RE
    J Nucl Med; 1996 Sep; 37(9):1540-5. PubMed ID: 8790215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anionic long circulation liposomes mediated antisense scintigraphy in tumor-bearing rats].
    Ma C; Kuang A; Huang R; Tang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):233-7. PubMed ID: 21604475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
    Roivainen A; Tolvanen T; Salomäki S; Lendvai G; Velikyan I; Numminen P; Välilä M; Sipilä H; Bergström M; Härkönen P; Lönnberg H; Långström B
    J Nucl Med; 2004 Feb; 45(2):347-55. PubMed ID: 14960659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization and body distribution of [¹³¹I]-herceptin in nude mice with BT-474 breast carcinoma.
    Yang ZX; Cao H; Xing CG; Wei SH; Jiang GQ; Liu ZL
    Genet Mol Res; 2014 Aug; 13(3):6804-12. PubMed ID: 25177959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.
    Lendvai G; Velikyan I; Bergström M; Estrada S; Laryea D; Välilä M; Salomäki S; Långström B; Roivainen A
    Eur J Pharm Sci; 2005 Sep; 26(1):26-38. PubMed ID: 15941654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue distribution of a DNA-methyltransferase antisense (MT-AS) oligonucleotide and its catabolites in tumor-bearing nude mice.
    Qian M; Chen SH; von Hofe E; Gallo JM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):663-70. PubMed ID: 9262328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of chemoresistance in vivo through the use of a radiolabeled antisense oligonucleotide.
    Touboul M; Gauchez AS; D'Hardemare Adu M; Lunardi J; Deverre JR; Pernin C; Mathieu JP; Vuillez JP; Fagret D
    Anticancer Res; 2002; 22(6A):3349-56. PubMed ID: 12530086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of free 211At and 125I- in nude mice bearing tumors derived from anaplastic thyroid carcinoma cell lines.
    Lundh C; Lindencrona U; Schmitt A; Nilsson M; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2006 Dec; 21(6):591-600. PubMed ID: 17257074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific imaging of hormone-dependent mammary carcinoma in nude mice with [131I]-anti-estriol 3-sulfate antibody.
    Shimura N; Kojima S; Kubodera A; Tsuruo T
    Nucl Med Biol; 1995 Jul; 22(5):547-53. PubMed ID: 7581162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor.
    Ou X; Tan T; He L; Li Y; Li J; Kuang A
    Cancer Gene Ther; 2005 Mar; 12(3):313-20. PubMed ID: 15578065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic studies on the 111In labeled antisense oligonucleotide for tumor imaging].
    Fujibayashi Y; Nakagawa K; Waki A; Sakahara H; Konishi J; Yokoyama A
    Kaku Igaku; 1996 Feb; 33(2):115-22. PubMed ID: 8721099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
    Reist CJ; Archer GE; Kurpad SN; Wikstrand CJ; Vaidyanathan G; Willingham MC; Moscatello DK; Wong AJ; Bigner DD; Zalutsky MR
    Cancer Res; 1995 Oct; 55(19):4375-82. PubMed ID: 7671250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
    Choi CW; Lang L; Lee JT; Webber KO; Yoo TM; Chang HK; Le N; Jagoda E; Paik CH; Pastan I
    Cancer Res; 1995 Nov; 55(22):5323-9. PubMed ID: 7585595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
    Nakamoto Y; Saga T; Misaki T; Kobayashi H; Sato N; Ishimori T; Kosugi S; Sakahara H; Konishi J
    J Nucl Med; 2000 Nov; 41(11):1898-904. PubMed ID: 11079502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.